Treatment licensed in US for people with active secondary progressive MS

28th March 2019

FDA approves the drug Siponimod, to treat people with active secondary progressive MS

Applications for 2019 MSIF Fellowships and Grants now open

18th March 2019

Deadline for MSIF's grants and fellowships is 21 July 2019.

How different disease modifying therapies can delay progression

26th February 2019

A new study examined different disease modifying therapies and their ability to slow the onset of secondary…

Treating MS in pregnancy

26th February 2019

MS affects at least twice as many more women than men, and it often strikes at an…

Screening environmental chemicals that may influence MS

26th February 2019

976 chemicals were screened to assess their impact on MS.

Stem cell trial results published

26th February 2019

A trial has compared a cancer chemotherapy to MS treatments, but further research is needed to understand…

Vacancy: Kiss Goodbye to MS Campaign Support Officer

18th February 2019

Exciting opportunity for a strong communicator to work on one of the only global fundraising campaign collaborations

Let’s talk about sex and MS

4th February 2019

We have collaborated with our members to adapt an animation that addresses some of the challenges of…

EME’s Tips to Help Quality of Life

1st February 2019

Multiple Sclerosis Spain has launched a new illustration with tips to help improve quality of life for…

Against MS Launches Worldwide

15th January 2019

Against MS is the DIY fundraising initiative for the MS International Federation because as the leaders of…

Chair of the People with MS Advisory Committee awarded for his services to MS

28th December 2018

Martin Stevens is awarded for his services to people with MS

Results released from first multi-drug clinical trial in MS

20th December 2018

The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have…